113 much of it remains manual, repetitive and difficult to scale. Biolevate is addressing this challenge with an AI knowledge platform built specifically for life sciences. Its platform supports use cases ranging from compiling systematic literature review feedback and recommendations to generating clinical study reports, running compliance checks, preparing common technical documents and regulatory intelligence. In other words, it focuses on the work that often determines whether promising science can move efficiently through the development and commercialisation process. Biolevate’s technology can significantly cut the time required for these activities. This offers significant promise for pharmaceutical and life sciences leaders: faster, defensible documentation that can accelerate submissions, improve collaboration and help ensure important therapies do not get delayed by operational bottlenecks. As a result, enterprises avoid wasting years developing a target that should never have been approved to move into the clinical development phase. Yet success in life sciences is not defined by approval alone. The final test is whether innovation improves the experience and outcomes of patients in the real world. That is where Dawn Health comes in. The company works with pharmaceutical partners to design, deploy and scale regulated digital health products that support patients and healthcare professionals across clinical trials, commercial programmes and ongoing disease management. PUBLIC SECTOR Biolevate's AI knowledge platform helps life sciences organisations expedite tasks like compiling systematic literature review feedback
RkJQdWJsaXNoZXIy NzQ1NTk=